Mesa Laboratories reported solid results for the fourth quarter of fiscal year 2025, with a 5.5% increase in total revenues and a significant increase in operating income. Core organic revenue growth was strong across all four divisions, and the company improved its balance sheet by reducing inventory and paying down debt.
Total revenues increased by 5.5% to $62.1 million in the fourth quarter of FY25.
Operating income increased by 100.5% to $1.5 million in the fourth quarter of FY25.
Non-GAAP core organic revenues growth was 6.3% for the fourth quarter of FY25.
The company generated $42.6 million of free cash flow in FY25, which was used primarily for debt reduction.
The company expects to continue reducing its past due backlog in the first two quarters of FY26. The impact of global tariffs is currently mitigated due to product switching barriers and a high recurring revenue mix, but the resolution of global trade is uncertain.
Visualization of income flow from segment revenue to net income